Quarterly report pursuant to Section 13 or 15(d)

5. Hybrid Debt Instrument (Details Narrative)

v3.5.0.2
5. Hybrid Debt Instrument (Details Narrative) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2016
Jun. 30, 2015
Jun. 30, 2016
Jun. 30, 2015
Loss on conversion $ (6,187,337) $ 0 $ (6,187,337) $ 0
Hybrid Debt Instrument [Member] | Pharmsynthez [Member]        
Stock issued for convertible note, shares issued     1,373,036  
Stock issued for convertible note, amount converted     $ 6,500,000  
Accrued interest converted     228,000  
Loss on conversion     (4,400,000)  
Interest expense $ 102,000   $ 347,000